Clinical Trials Logo

Paralysis clinical trials

View clinical trials related to Paralysis.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT05338229 Withdrawn - Clinical trials for Upper Extremity Problem

Kinect Sensor in Cerebral Palsy Children: Phase 2.1

Start date: June 2022
Phase: N/A
Study type: Interventional

There are 3 phases of the study. This registration is phase 2.1.This registration will conduct a pilot study in the cerebral palsy children.

NCT ID: NCT05041114 Withdrawn - Clinical trials for Amyotrophic Lateral Sclerosis

SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis

Start date: April 21, 2022
Phase: N/A
Study type: Interventional

The Synchron Motor Neuroprosthesis (MNP) is intended to be used in subjects with severe motor impairment, unresponsive to medical or rehabilitative therapy and a persistent functioning motor cortex. The purpose of this research is to evaluate safety and feasibility. The MNP is a type of implantable brain computer interface which bypasses dysfunctional motor neurons. The device is designed to restore the transmission of neural signal from the cerebral cortex utilized for neuromuscular control of digital devices, resulting in a successful execution of non-mechanical digital commands.

NCT ID: NCT04761666 Withdrawn - Osteoporosis Clinical Trials

Influence of Verticalization on Bone Mineral Density and Biological Parameters of Bone Remodeling in Children With Severe Cerebral Palsy

CPABONE
Start date: February 16, 2021
Phase:
Study type: Observational

Low bone mineral density affects 77% of children with severe cerebral palsy (GMFCS IV & V) with an increased fracture risk of 4%. One strategy supposed to improve bone mineral density is verticalisation with static devices. Nowadays there is no time recommendation of verticalisation however high intensity verticalisation has been shown to be effective in improving bone mineral density in childrens with cerebral palsy, but difficult to apply in real life due to lack of qualified therapists, device's complexity, and severe impairment in those children. The investigators aim to compare bone mineral density and bone remodelling factors of verticalized and non verticalized childrens with severe cerebral palsy as achieved in everyday life. The investigators conduced a retrospective study comparing bone mineral density and factors who influence bone remolling in severe cerebral palsy's according to whether they are verticalized or not.

NCT ID: NCT03622697 Withdrawn - Facial Paralysis Clinical Trials

Effects of Mindfulness Meditation on Facial Paralysis Patients

Start date: July 2021
Phase: N/A
Study type: Interventional

Currently, physicians have several options in addressing the anatomic and physiologic sequela of facial paralysis. However, strategies to address the psychologic and coping ability for patients have not been investigated. The goal is to investigate the effect of mindfulness meditation on social functioning in patients with facial paralysis. This study will also explore whether increasing social functioning in patients with facial paralysis will improve overall quality of life. These questions will be answered using a randomized controlled trial.

NCT ID: NCT03457025 Withdrawn - Bell Palsy Clinical Trials

Effect of Adjuvant Hyperbaric Oxygen Therapy on Bells Palsy Outcome

Start date: August 2019
Phase: Early Phase 1
Study type: Interventional

This is a randomized, single blinded, non-placebo controlled that will compare one group of Bells Palsy patients receiving the current standard of care including oral corticosteroids and oral antivirals against an experimental group receiving the current standard of care in addition to hyperbaric oxygen therapy. Outcome assessment will be based on both objective analyses of facial movements as well as subjective quality of life scales.

NCT ID: NCT03097159 Withdrawn - Clinical trials for Phrenic Nerve Paralysis

Comparison of Costoclavicular Brachial Plexus Block and Supraclavicular Brachial Plexus Block

BPB
Start date: May 1, 2017
Phase:
Study type: Observational

The investigator will compare Costoclavicular approach of infraclavicular block and supraclavicular block. Especially, the incidence of phrenic nerve palsy and the quality of block.

NCT ID: NCT02899858 Withdrawn - Spinal Cord Injury Clinical Trials

Restoration of Standing and Walking With ISMS in Humans

ISMS
Start date: January 2015
Phase: N/A
Study type: Interventional

Spinal cord neural circuitry exists in the lumbar enlargement that makes it possible to stand and create synergistic, rhythmic stepping activity in the lower limbs. In the past 20 years, clinicians have tried to reengage such these circuits for standing and walking in the lower spinal cord of paralyzed humans through novel paradigms of physical therapy, pharmacological stimulation of the spinal cord, or recently - epidural stimulation of the spinal cord. Although standing and stepping with these maneuvers are rudimentary at best, these human studies offer promise to restore controlled, lower extremity movement to the spinal cord injured (SCI) individual. Evidence from animal data suggests that more focal activation of intraspinal circuitry (IntraSpinal Micro-Stimulation - ISMS) would produce more fatigue resistant, natural standing and stepping activity in humans. To date, there has been no direct confirmation of such circuitry in the spinal cord of bipedal humans who have been paralyzed. Furthermore, mapping of such circuitry would provide the basis of a novel intraspinal neuroprosthetic that should be able to restore control of standing or walking in a manner that is much more physiologically normal and tolerable than by stimulating each individual muscle group. Proof of the existence of these spinal circuits in man, and the ability to activate and control these circuits by first mapping the spinal cord is the basis of this proposal.

NCT ID: NCT02241395 Withdrawn - Cerebral Palsy Clinical Trials

Cell Therapy as Treatment for Cerebral Palsy

Start date: August 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study was to study the effect of autologous bone marrow mononuclear cells on common symptoms of cerebral palsy patients.

NCT ID: NCT01978821 Withdrawn - Cerebral Palsy Clinical Trials

Stem Cell Therapy for Cerebral Palsy

Start date: August 2010
Phase: Phase 1
Study type: Interventional

the purpose of this study was to study the effect of stem cell therapy on common symptoms of cerebral palsy patients.

NCT ID: NCT01386255 Withdrawn - Cerebral Palsy Clinical Trials

Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy

Start date: April 2009
Phase: Phase 4
Study type: Interventional

Despite the use of proton pump inhibitors and available prokinetics, medical therapy is ineffective in an important number of children with cerbreal palsy (CP) and gastroesophageal reflux disease (GERD), and failure of medical therapy is associated with a substantial morbidity. Many patients, particularly children with CP and GERD, continue to experience complications despite aggressive therapy because antisecretory medications do not address the primary reflux mechanism (TLESR). Furthermore, in patients with CP, surgical options are fraught with serious complications and long-term morbidity. Because the available treatment options for children with CP and intractable GERD are limited, new therapies are urgently needed. Baclofen, which has been shown in animals and humans to decrease TLESRs, may be a good alternative for the treatment of children with CP with intractable GERD.